Reuters logo
BRIEF-Galmed Pharma Q1 loss per share $0.26
2017年5月15日 / 中午12点20分 / 4 个月前

BRIEF-Galmed Pharma Q1 loss per share $0.26

May 15 (Reuters) - Galmed Pharmaceuticals Ltd

* Galmed pharmaceuticals reports first quarter 2017 financial results

* Q1 loss per share $0.26

* Q1 earnings per share view $-0.38 -- Thomson Reuters I/B/E/S

* Q1 revenue $300,000 versus i/b/e/s view $258,000

* Galmed pharmaceuticals - continues to believe that its cash balance will be sufficient to maintain its current operations through first half of 2018 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below